Ilyang Pharm (007570) — Cash Flow Reinvestment Rate
Ilyang Pharm (007570) has a Cash Flow Reinvestment Rate of 3.94x as of June 2025, reinvesting ₩8.90 Billion (capex ₩3.32 Billion plus investments ₩-5.59 Billion) from operating cash flow of ₩2.26 Billion. Explore how much does Ilyang Pharm reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ilyang Pharm Cash Flow Reinvestment Rate (2003–2024)
Historical reinvestment intensity for Ilyang Pharm across 12 annual periods. Also explore Ilyang Pharm balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ilyang Pharm (2003–2024)
Year-by-year capital reinvestment analysis for Ilyang Pharm. For live market cap and broader valuation context, see market value of Ilyang Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.86x | ₩77.80 Billion | ₩5.61 Billion | ₩40.62 Billion | ▲ +984.2% |
| 2023 | 1.28x | ₩17.05 Billion | ₩13.34 Billion | ₩6.47 Billion | ▲ +18.8% |
| 2022 | 1.08x | ₩32.20 Billion | ₩29.94 Billion | ₩4.08 Billion | ▲ +434.9% |
| 2021 | 0.20x | ₩13.48 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +12.3% |
| 2020 | 0.18x | ₩10.29 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.2% |
| 2019 | 0.24x | ₩8.67 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +104.4% |
| 2018 | 0.12x | ₩2.59 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -53.7% |
| 2017 | 0.25x | ₩7.60 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -67.4% |
| 2016 | 0.78x | ₩20.98 Billion | ₩26.98 Billion | ₩10.31 Billion | ▲ +87.2% |
| 2015 | 0.42x | ₩16.72 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -44.4% |
| 2014 | 0.75x | ₩13.92 Billion | ₩18.63 Billion | ₩13.89 Billion | ▲ +1715.2% |
| 2003 | 0.04x | ₩415.11 Million | ₩10.08 Billion | ₩415.11 Million | — |